Making a Difference: Dr. Kenneth Miller and Vision Harvest 2024
December 13, 2024June Is Cataract Awareness Month: Take Steps Toward Clearer Vision
June 2, 2025How the Laser Vision Correction Center of New Jersey Can Help Diagnose and Treat Dry AMD with Cutting-Edge Technology
February is AMD Awareness Month, a time to focus on age-related macular degeneration (AMD) and raise awareness about this leading cause of vision loss in individuals over 50. As we observe this important month, it’s essential to highlight both the challenges that come with AMD and the advanced treatments now available to help manage this condition. At the Laser Vision Correction Center in New Jersey, we are proud to offer innovative solutions to help diagnose and treat dry AMD with the latest technology, including Valeda—an exciting new photobiomodulation (PBM) light therapy that is the first and only FDA-authorized treatment for the earlier stages of dry age-related macular degeneration (AMD), and the only treatment shown to improve vision.
Understanding Dry AMD
Age-related macular degeneration (AMD) is a progressive eye condition that affects the macula, the part of the retina responsible for central vision. While there are two types of AMD—wet and dry—dry AMD is the most common form, accounting for about 85-90% of all AMD cases. As the condition progresses, individuals with dry AMD experience a gradual decline in their central vision, making it difficult to read, drive, and perform other daily activities.
Currently, there is no cure for dry AMD, but early diagnosis and treatment can slow its progression and preserve vision for as long as possible. This is where the Laser Vision Correction Center of New Jersey stands out, offering state-of-the-art diagnostic tools and breakthrough therapies like Valeda to provide patients with the best care possible.
Cutting-Edge Technology: Valeda Photobiomodulation Therapy
At the Laser Vision Correction Center of New Jersey, we are excited to be the first practice in New Jersey to offer Valeda, a revolutionary photobiomodulation (PBM) therapy that targets dry AMD. Valeda uses light therapy to stimulate the retina, promoting cellular repair and reducing inflammation. This innovative technology, which was just recently approved by the FDA, has shown promising results in improving vision and slowing the progression of dry AMD.
Valeda works by delivering specific wavelengths of light to the retina, stimulating the mitochondria within the cells. This process helps to increase cellular energy, promote tissue repair, and reduce oxidative stress, which is a key factor in the progression of AMD. By improving the health of retinal cells, Valeda helps slow down vision loss and may even enhance vision in some patients.
How Valeda Can Help Dry AMD Patients
The beauty of Valeda is its non-invasive nature. Patients undergoing Valeda therapy do not need to worry about needles, injections, or surgery. Instead, the therapy involves precise light pulses to the eyes in a comfortable and safe manner. Treatment sessions are typically quick, with patients experiencing minimal discomfort, if any.
The Laser Vision Correction Center of New Jersey is proud to be the first comprehensive practice in New Jersey to offer Valeda therapy, giving our patients access to a game-changing treatment that can have a significant impact on managing dry AMD. By incorporating this cutting-edge technology into our treatment plans, we can offer hope and real solutions to individuals battling the challenges of AMD.
Early Detection Is Key
As with any eye condition, early detection is critical when it comes to AMD. The Laser Vision Correction Center of New Jersey uses advanced diagnostic tools to detect early signs of AMD, often before symptoms become noticeable. Through comprehensive eye exams, including retina imaging, we can assess the health of your retina and identify any changes that may indicate the presence of AMD.
If you’re at risk for AMD, whether due to age, family history, or other risk factors, it’s important to schedule regular eye exams to monitor your eye health. Early intervention is key to preserving vision, and the Laser Vision Correction Center is here to help every step of the way.
Why Choose the Laser Vision Correction Center of New Jersey?
As a leader in eye care, the Laser Vision Correction Center of New Jersey has always been committed to staying at the forefront of medical technology. Our team of experienced doctors and technicians works tirelessly to ensure that our patients receive the best care possible. By offering the latest treatments like Valeda and using cutting-edge diagnostic tools, we are able to provide comprehensive care for patients with dry AMD.
Whether you’re looking to prevent AMD or need treatment for an existing diagnosis, our center is here to guide you through the process. We take the time to explain your condition, answer your questions, and develop a personalized treatment plan that suits your needs.
Schedule Your Consultation Today
If you or a loved one is living with dry AMD, don’t wait, take the first step toward better vision today. Schedule a consultation with the Laser Vision Correction Center of New Jersey to learn more about Valeda and how we can help manage your condition. Our team is dedicated to providing the most advanced care to help you maintain your vision and quality of life.
During AMD Awareness Month, we’re reminded that vision is a precious gift, and there are new advancements that can help protect it. The doctors at our practice are here to support you with the best care and the latest treatments available.
Contact us today to schedule your eye exam and discover how Valeda can help manage dry AMD!
Your eyes deserve the best! Let us help you see the world with clarity and confidence.
View more information about Valeda Photobiomodulation Therapy in the links below.
https://www.aao.org/eye-health/news/light-therapy-photobiomodulation-dry-amd-ga
https://retinatoday.com/articles/2020-may-june/photobiomodulation-as-a-treatment-in-dry-amd
https://www.aao.org/newsroom/news-releases/detail/could-light-therapy-treat-dry-amd
LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMD Patients to Improve Vision